|
FASTK expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62558855265615E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.17204073907851E-14 |
| Normal-vs-Stage2 |
4.115500E-03 |
| Normal-vs-Stage3 |
1.133570E-02 |
| Normal-vs-Stage4 |
3.092200E-01 |
| Stage1-vs-Stage2 |
2.375400E-01 |
| Stage1-vs-Stage3 |
5.822400E-03 |
| Stage1-vs-Stage4 |
6.650300E-02 |
| Stage2-vs-Stage3 |
3.994200E-01 |
| Stage2-vs-Stage4 |
3.014400E-01 |
| Stage3-vs-Stage4 |
6.355400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.66453525910038E-15 |
| Normal-vs-AfricanAmerican |
1.61460000003277E-06 |
| Normal-vs-Asian |
1.925020E-01 |
| Caucasian-vs-AfricanAmerican |
4.592000E-01 |
| Caucasian-vs-Asian |
4.504600E-01 |
| AfricanAmerican-vs-Asian |
6.437800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.61791999999661E-05 |
| Male-vs-Female |
5.597800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.246900E-04 |
| Normal-vs-Extreme_Weight |
6.42597086653041E-13 |
| Normal-vs-Obese |
1.91299999952044E-07 |
| Normal-vs-Extreme_Obese |
6.719600E-03 |
| Normal_Weight-vs-Extreme_Weight |
4.512000E-01 |
| Normal_Weight-vs-Obese |
7.274600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.820600E-01 |
| Extreme_Weight-vs-Obese |
9.265800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.357800E-01 |
| Obese-vs-Extreme_Obese |
1.846590E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.012300E-02 |
| Normal-vs-Age(41-60Yrs) |
3.97926136486149E-12 |
| Normal-vs-Age(61-80Yrs) |
2.32924790566358E-13 |
| Normal-vs-Age(81-100Yrs) |
8.919500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.362800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.232000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.812800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.896000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.400400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.840600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
4.742300E-02 |
| Normal-VS-KIRP CIMP |
8.416000E-01 |
| Normal-VS-Unclassified PRCC |
1.73436999999499E-05 |
| Type1 PRCC-VS-Type2 PRCC |
1.62447832963153E-12 |
| Type1 PRCC-VS-KIRP CIMP |
6.10870021233723E-10 |
| Type1 PRCC-VS-Unclassified PRCC |
5.560300E-04 |
| Type2 PRCC-VS-KIRP CIMP |
3.813200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.004500E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
2.246000E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.77509999996517E-06 |
| Normal-vs-N1 |
1.244820E-01 |
| Normal-vs-N2 |
1.535920E-02 |
| N0-vs-N1 |
3.133900E-02 |
| N0-vs-N2 |
6.431800E-01 |
| N1-vs-N2 |
4.748800E-01 |
|
|
